Review
Copyright copy;2010 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2010; 16(39): 4913-4921
Published online Oct 21, 2010. doi: 10.3748/wjg.v16.i39.4913
Table 4 Food and Drug Administration approved drugs for prophylaxis and treatment of hereditary angioedema attacks[18,34,35,37,38,40]
DrugFDA approved indicationUsual adult doseRange
CinryzeProphylaxis1000 units IVEvery 3rd or 4th day
DanazolProphylaxis200 mg/d100 mg every 3rd day to 600 mg/d
BerinertAcute attacks20 units/kg body weight IVPer attack
IcatibantAcute attacks30 mg SQPer attack
EcallantideAcute attacks30 mg SQPer attack